During the past decade, Narodny ustav srdcovych a cievnych chorob, a. s. conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 10 clinical trials were completed, i.e. on average, 55.6% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 4 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Narodny ustav srdcovych a cievnych chorob, a. s." #1 sponsor was "Medtronic Cardiac Rhythm and Heart Failure" with 4 trials, followed by "Actelion" with 3 trials sponsored, "Medtronic BRC" with 3 trials sponsored, "Amgen" with 2 trials sponsored and "Biotronik SE & Co. KG" with 2 trials sponsored. Other sponsors include 11 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Narodny ustav srdcovych a cievnych chorob, a. s." #1 collaborator was "Biotronik, Inc." with 1 trials as a collaborator, "Charles University, Czech Republic" with 1 trials as a collaborator and "NAMSA" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Narodny ustav srdcovych a cievnych chorob, a. s." are "Heart Failure" (7 trials), "Atrial Fibrillation" (3 trials), "Cardiovascular Disease" (2 trials), "Chronic Thromboembolic Pulmonary Hypertension" (2 trials) and "Acute Myocardial Infarction" (1 trials). Many other conditions were trialed in "Narodny ustav srdcovych a cievnych chorob, a. s." in a lesser frequency.

Most popular intervention types in "Narodny ustav srdcovych a cievnych chorob, a. s." are "Device" (13 trials), "Drug" (9 trials), "Other" (6 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "bococizumab (PF-04950615)" (2 trials), "46 hrs Holter ECG recording" (1 trials), "Akern BIA101 and Custom Device" (1 trials) and "Cangrelor" (1 trials). Other intervention names were less common.

The vast majority of trials in "Narodny ustav srdcovych a cievnych chorob, a. s." are 30 trials for "All" genders.

Currently, there are NaN active trials in "Narodny ustav srdcovych a cievnych chorob, a. s.". undefined are not yet recruiting, 10 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Narodny ustav srdcovych a cievnych chorob, a. s., undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Narodny ustav srdcovych a cievnych chorob, a. s., 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 8 trials that are defined as “Not Applicable".